Wolfgang C. Winkelmayer, MD, ScD
Academic Appointments
- Associate Professor, Medicine - Nephrology
- Associate Professor (By courtesy), Health Research & Policy
Key Documents
Contact Information
-
Clinical Offices
Nephrology Division 300 Pasteur Dr S201 MC 5114 Stanford, CA 94305 Tel Work (650) 723-6961 Fax (650) 725-8418Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Alternate Contact Linda Enomoto Tel Work (650) 723-5096Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Nephrology
Administrative Appointments
- Director of Clinical Research, Stanford University School of Medicine, Division of Nephrology (2009 - present)
- Director of Renal Drug Evaluation and Outcomes Research, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (2004 - 2009)
Honors and Awards
- Fellowship Teaching Award, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (2009)
- Norman S. Coplon Extramural Research Program Award, Satellite Healthcare, Mountain View, CA (2005)
- T. Franklin Williams Scholar, Association of Subspecialty Professors (2004)
Professional Education
| Fellowship: | Brigham and Women's Hospital, Harvard Medical School, MA USA (2009) |
| Sc.D.: | Harvard School of Public Health, Health Policy and Management (2001) |
| M.P.H.: | Harvard School of Public Health, Health Care Management (1999) |
| Residency: | Kaiser Franz Josef-Spital, Austria (1999) |
| Medical Education: | University of Vienna, Austria (1990) |
| Residency: | Joachim Huber, MD (Private Practice), Austria (1992) |
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
Working as a clinical nephrologist in my native Vienna, Austria, I was struck by the abysmal outcomes and quality of life experienced by the patients for whom I cared. I was equally struck by the absence of quality evidence that would guide us in our treatment of these vulnerable patients. Seeking to make a difference, I sought and underwent doctoral training in health policy and epidemiology at Harvard, with the career goal to conduct high quality research that would fill important evidence gaps in our field. At Brigham and Womens Hospital, I joined the Division of Pharmacoepidemiology where I learned from some of the leaders in the field how to conduct quality comparative effectiveness research long before it became a buzz-word. My immediate colleagues and the wider environment at Harvard Medical School enabled me to master and apply the most novel analytical approaches that are necessary to tackle difficult problems in the presence of confounding by indication, a dreaded threat to validity in comparative effectiveness research. I was able to build a group of colleagues that shared a passion for drug utilization and comparative effectiveness research in kidney disease, cardiovascular disease, and diabetes, and we were able to publish our findings in leading journals.
Having recently moved to Stanford, I am in the process of building a young research group that will again focus on comparative effectiveness research. Here, I am once again in the privileged position to build on a fabulous research environment and an exquisite wealth of knowledge and experience represented by the scientists and clinicians on and off campus. With the enthusiastic support and collaborations of my colleagues here at Stanford as well as at other institutions in the U.S. and Europe, I am confident that we will provide important contributions that will guide us towards more evidence based and effective care of our patients with kidney disease. Doing so will hopefully contribute to improving the lives of these vulnerable patients, which is my explicit career goal.
Publications
- Treated and untreated kidney failure in older adults: what's the right balance? JAMA. 2012; (23): 2545-6
- Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011; (15): 1371-8
- Tackling the Achilles' heel of hemodialysis. N Engl J Med. 2011; (4): 372-4
- Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA. 2010; (9): 857-64
- Altitude and all-cause mortality in incident dialysis patients. JAMA. 2009; (5): 508-12
- Determinants of peritoneal dialysis technique failure in incident US patients. Perit Dial Int. 2013 Mar-Apr; (2): 155-66
Help
Internal Staff Login